Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Leukemia

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 42 articles:
HTML format
Text format



Single Articles


    June 2019
  1. LIU C, Li Y, Hu R, Han W, et al
    Knockdown of ribonucleotide reductase regulatory subunit M2 increases the drug sensitivity of chronic myeloid leukemia to imatinibbased therapy.
    Oncol Rep. 2019 Jun 11. doi: 10.3892/or.2019.7194.
    PubMed     Text format     Abstract available


  2. SAKURAI N, Komada Y, Hanaki R, Morimoto M, et al
    Role of microRNAs in glucocorticoidresistant Bcell precursor acute lymphoblastic leukemia.
    Oncol Rep. 2019 Jun 10. doi: 10.3892/or.2019.7191.
    PubMed     Text format     Abstract available


  3. YU X, Zhang H, Yuan M, Zhang P, et al
    Identification and characterization of a murine model of BCRABL1+ acute Blymphoblastic leukemia with central nervous system metastasis.
    Oncol Rep. 2019 Jun 3. doi: 10.3892/or.2019.7184.
    PubMed     Text format     Abstract available


  4. ZHANG R, Deng Q, Jiang YY, Zhu HB, et al
    Effect and changes in PD1 expression of CD19 CART cells from T cells highly expressing PD1 combined with reduceddose PD1 inhibitor.
    Oncol Rep. 2019;41:3455-3463.
    PubMed     Text format     Abstract available


    May 2019
  5. BRIGHT SA, Byrne AJ, Vandenberghe E, Browne PV, et al
    Selected nitrostyrene compounds demonstrate potent activity in chronic lymphocytic leukaemia cells, including those with poor prognostic markers.
    Oncol Rep. 2019;41:3127-3136.
    PubMed     Text format     Abstract available


    April 2019
  6. BAI J, Li L, Li Y, Chen Q, et al
    Methylation of the promoter region of the MTRR gene in childhood acute lymphoblastic leukemia.
    Oncol Rep. 2019 Apr 12. doi: 10.3892/or.2019.7114.
    PubMed     Text format     Abstract available


  7. IBRAHIM SM, Bakhashab S, Ilyas AM, Pushparaj PN, et al
    WYE-354 restores Adriamycin sensitivity in multidrug-resistant acute myeloid leukemia cell lines.
    Oncol Rep. 2019 Apr 2. doi: 10.3892/or.2019.7093.
    PubMed     Text format     Abstract available


  8. YANG Y, Dai W, Sun Y, Zhao Z, et al
    Long noncoding RNA linc00239 promotes malignant behaviors and chemoresistance against doxorubicin partially via activation of the PI3K/Akt/mTOR pathway in acute myeloid leukaemia cells.
    Oncol Rep. 2019;41:2311-2320.
    PubMed     Text format     Abstract available


    March 2019
  9. HUANG R, Liao X, Li J, Wei J, et al
    Genome-scale integrated analysis to identify prospective molecular mechanisms and therapeutic targets in isocitrate dehydrogenase 2 R140Q-mutated acute myeloid leukemia.
    Oncol Rep. 2019 Mar 18. doi: 10.3892/or.2019.7075.
    PubMed     Text format     Abstract available


  10. WANG H, Dong R, Fan WW, Zheng XC, et al
    Timosaponin AIII induces autophagy of Tcell acute lymphoblastic leukemia Jurkat cells via inhibition of the PI3K/Akt/mTOR pathway.
    Oncol Rep. 2019 Mar 15. doi: 10.3892/or.2019.7072.
    PubMed     Text format     Abstract available


  11. LI Y, Zhao L, Li N, Miao Y, et al
    [Corrigendum] miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1.
    Oncol Rep. 2019 Mar 13. doi: 10.3892/or.2019.7057.
    PubMed     Text format     Abstract available


  12. LEE HR, Baek KH
    Role of natural killer cells for immunotherapy in chronic myeloid leukemia (Review).
    Oncol Rep. 2019 Mar 13. doi: 10.3892/or.2019.7059.
    PubMed     Text format     Abstract available


  13. BASHANFER SAA, Saleem M, Heidenreich O, Moses EJ, et al
    Disruption of MAPK1 expression in the ERK signalling pathway and the RUNX1RUNX1T1 fusion gene attenuate the differentiation and proliferation and induces the growth arrest in t(8;21) leukaemia cells.
    Oncol Rep. 2019;41:2027-2040.
    PubMed     Text format     Abstract available


    January 2019
  14. PILLOZZI S, Bernini A, Spiga O, Lelli B, et al
    Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrowinduced chemoresistance in acute leukemias.
    Oncol Rep. 2019;41:312-324.
    PubMed     Text format     Abstract available


    December 2018
  15. JIANG M, Zou X, Lu L
    Potential efficacy and prognosis of silencing the CRLF2mediated AKT/mTOR pathway in pediatric acute Bcell lymphoblastic leukemia.
    Oncol Rep. 2018 Dec 7. doi: 10.3892/or.2018.6917.
    PubMed     Text format     Abstract available


  16. FU J, Si L, Zhuang Y, Zhang A, et al
    Wnt/betacatenin inhibition reverses multidrug resistance in pediatric acute lymphoblastic leukemia.
    Oncol Rep. 2018 Dec 4. doi: 10.3892/or.2018.6902.
    PubMed     Text format     Abstract available


    November 2018
  17. JING W, Li J
    Identification of biomarkers for the prediction of relapsefree survival in pediatric Bprecursor acute lymphoblastic leukemia.
    Oncol Rep. 2018 Nov 2. doi: 10.3892/or.2018.6846.
    PubMed     Text format     Abstract available


  18. ZHANG C, Guo LY, Mu D, Gong JH, et al
    Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin.
    Oncol Rep. 2018 Nov 2. doi: 10.3892/or.2018.6849.
    PubMed     Text format     Abstract available


    October 2018
  19. RYU I, Ryu MJ, Han J, Kim SJ, et al
    LDeprenyl exerts cytotoxicity towards acute myeloid leukemia through inhibition of mitochondrial respiration.
    Oncol Rep. 2018 Oct 1. doi: 10.3892/or.2018.6753.
    PubMed     Text format     Abstract available


    September 2018
  20. ZHAO W, Wang L, Yu Y
    Gene module analysis of juvenile myelomonocytic leukemia and screening of anticancer drugs.
    Oncol Rep. 2018 Sep 18. doi: 10.3892/or.2018.6709.
    PubMed     Text format     Abstract available


  21. PANG X, Wang Y, Zhang S, Tan Z, et al
    Altered susceptibility to apoptosis and Nglycan profiles of hematopoietic KG1a cells following coculture with bone marrowderived stromal cells under hypoxic conditions.
    Oncol Rep. 2018;40:1477-1486.
    PubMed     Text format     Abstract available


    August 2018
  22. ZHAO Y, Zhong L, Liu L, Yao SF, et al
    Salinomycin induces apoptosis and differentiation in human acute promyelocytic leukemia cells.
    Oncol Rep. 2018;40:877-886.
    PubMed     Text format     Abstract available


    June 2018
  23. YU J, Guo XL, Bai YY, Yang JJ, et al
    Genomewide profiling of lncRNA expression patterns in patients with acute promyelocytic leukemia with differentiation therapy.
    Oncol Rep. 2018 Jun 25. doi: 10.3892/or.2018.6521.
    PubMed     Text format     Abstract available


  24. ZHANG XH, Yang L, Liu XJ, Zhan Y, et al
    Association between methylation of tumor suppressor gene SOCS1 and acute myeloid leukemia.
    Oncol Rep. 2018 Jun 19. doi: 10.3892/or.2018.6508.
    PubMed     Text format     Abstract available


    May 2018
  25. ZOVKO A, Yektaei-Karin E, Salamon D, Nilsson A, et al
    Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis.
    Oncol Rep. 2018 May 25. doi: 10.3892/or.2018.6465.
    PubMed     Text format     Abstract available


    April 2018
  26. CHEN N, Feng L, Qu H, Lu K, et al
    Overexpression of IL-9 induced by STAT3 phosphorylation is mediated by miR-155 and miR-21 in chronic lymphocytic leukemia.
    Oncol Rep. 2018 Apr 12. doi: 10.3892/or.2018.6367.
    PubMed     Text format     Abstract available


    February 2018
  27. MA X, Zhou X, Qu H, Ma Y, et al
    TRIB2 knockdown as a regulator of chemotherapy resistance and proliferation via the ERK/STAT3 signaling pathway in human chronic myelogenous leukemia K562/ADM cells.
    Oncol Rep. 2018 Feb 7. doi: 10.3892/or.2018.6249.
    PubMed     Text format     Abstract available


  28. DONG L, Xu WW, Li H, Bi KH, et al
    In vitro and in vivo anticancer effects of marmesin in U937 human leukemia cells are mediated via mitochondrial-mediated apoptosis, cell cycle arrest, and inhibition of cancer cell migration.
    Oncol Rep. 2018;39:597-602.
    PubMed     Text format     Abstract available


    January 2018
  29. LI GY, Liu JZ, Zhang L, Liu GZ, et al
    Knockdown of immature colon carcinoma transcript 1 induces suppression of proliferation, S-phase arrest and apoptosis in leukemia cells.
    Oncol Rep. 2018 Jan 3. doi: 10.3892/or.2018.6185.
    PubMed     Text format     Abstract available


  30. LEE KW, Um ES, Jung BB, Choi ES, et al
    Rhus verniciflua Stokes extract induces inhibition of cell growth and apoptosis in human chronic myelogenous leukemia K562 cells.
    Oncol Rep. 2018 Jan 3. doi: 10.3892/or.2018.6179.
    PubMed     Text format     Abstract available


  31. HUANG R, Liu H, Chen Y, He Y, et al
    EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway.
    Oncol Rep. 2018;39:119-128.
    PubMed     Text format     Abstract available


    December 2017
  32. LIN MW, Yang JS, Lu CC, Lin C, et al
    2-Phenyl-4-quinolone (YT-1) induces G2/M phase arrest and an intrinsic apoptotic mechanism in human leukemia cells.
    Oncol Rep. 2017 Dec 20. doi: 10.3892/or.2017.6170.
    PubMed     Text format     Abstract available


    November 2017
  33. YANG JS, Lee CY, Cho HC, Lu CC, et al
    ITR284 modulates cell differentiation in human chronic myelogenous leukemia K562 cells.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6090.
    PubMed     Text format     Abstract available


    September 2017
  34. SHEN Y, Liu Q, Lou S, Luo Y, et al
    Decreased expression of the augmenter of liver regeneration results in growth inhibition and increased chemosensitivity of acute T lymphoblastic leukemia cells.
    Oncol Rep. 2017 Sep 21. doi: 10.3892/or.2017.5984.
    PubMed     Text format     Abstract available


    July 2017
  35. HUANG JL, Liu W, Tian LH, Chai TT, et al
    Upregulation of long non-coding RNA MALAT-1 confers poor prognosis and influences cell proliferation and apoptosis in acute monocytic leukemia.
    Oncol Rep. 2017 Jul 10. doi: 10.3892/or.2017.5802.
    PubMed     Text format     Abstract available


    June 2017
  36. HAN XJ, Shi SL, Wei YF, Jiang LP, et al
    Involvement of mitochondrial dynamics in the antineoplastic activity of cisplatin in murine leukemia L1210 cells.
    Oncol Rep. 2017 Jun 28. doi: 10.3892/or.2017.5765.
    PubMed     Text format     Abstract available


  37. JI Y, Ma Y, Chen X, Ji X, et al
    Microvesicles released from human embryonic stem cell derived-mesenchymal stem cells inhibit proliferation of leukemia cells.
    Oncol Rep. 2017 Jun 16. doi: 10.3892/or.2017.5729.
    PubMed     Text format     Abstract available


  38. LIU Y, Shin DY, Oh S, Kim S, et al
    KML001 and doxercalciferol induce synergistic antileukemic effect in acute lymphoid leukemia cells.
    Oncol Rep. 2017 Jun 1. doi: 10.3892/or.2017.5688.
    PubMed     Text format     Abstract available


  39. KONG X, Luo J, Xu T, Zhou Y, et al
    Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP.
    Oncol Rep. 2017;37:3423-3432.
    PubMed     Text format     Abstract available


  40. KIM DM, Jang H, Shin MG, Kim JH, et al
    beta-catenin induces expression of prohibitin gene in acute leukemic cells.
    Oncol Rep. 2017;37:3201-3208.
    PubMed     Text format     Abstract available


    May 2017
  41. ZHOU HR, Fu HY, Wu DS, Zhang YY, et al
    Relationship between epigenetic changes in Wnt antagonists and acute leukemia.
    Oncol Rep. 2017;37:2663-2671.
    PubMed     Text format     Abstract available


    March 2017
  42. CHEN JR, Jia XH, Wang H, Yi YJ, et al
    With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells.
    Oncol Rep. 2017 Mar 29. doi: 10.3892/or.2017.5535.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: